Literature DB >> 21193205

Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure.

Timothy L McCavit1, Charles T Quinn, Chonnamet Techasaensiri, Zora R Rogers.   

Abstract

Invasive pneumococcal disease (IPD) in children with sickle cell disease has decreased with prophylactic penicillin, pneumococcal polysaccharide vaccine, and pneumococcal protein-conjugate vaccine usage. We report 10 IPD cases since pneumococcal protein-conjugate vaccine licensure, including a recent surge of non-vaccine serotypes. IPD continues to be a serious risk in sickle cell disease.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21193205      PMCID： PMC3062091          DOI： 10.1016/j.jpeds.2010.11.025

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  13 in total

1.  Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults.

Authors:  Daniel A Scott; Steven F Komjathy; Branda T Hu; Sherryl Baker; Lois A Supan; Carol A Monahan; William Gruber; George R Siber; Stephen P Lockhart
Journal:  Vaccine       Date:  2007-06-26       Impact factor: 3.641

2.  Natural history of sickle cell disease--the first ten years.

Authors:  D R Powars
Journal:  Semin Hematol       Date:  1975-07       Impact factor: 3.851

3.  Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.

Authors:  Ian A Critchley; Michael R Jacobs; Steven D Brown; Maria M Traczewski; Glenn S Tillotson; Nebojsa Janjic
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

4.  Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.

Authors:  A J Ammann; J Addiego; D W Wara; B Lubin; W B Smith; W C Mentzer
Journal:  N Engl J Med       Date:  1977-10-27       Impact factor: 91.245

5.  Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

Authors:  M H Gaston; J I Verter; G Woods; C Pegelow; J Kelleher; G Presbury; H Zarkowsky; E Vichinsky; R Iyer; J S Lobel
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

6.  Functional asplenia in sickle-cell anemia.

Authors:  H A Pearson; R P Spencer; E A Cornelius
Journal:  N Engl J Med       Date:  1969-10-23       Impact factor: 91.245

Review 7.  Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature.

Authors:  E Barrett-Connor
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

8.  Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

Authors:  Natasha B Halasa; Sadhna M Shankar; Thomas R Talbot; Patrick G Arbogast; Ed F Mitchel; Winfred C Wang; William Schaffner; Allen S Craig; Marie R Griffin
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

9.  Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.

Authors:  Thomas V Adamkiewicz; Benjamin J Silk; James Howgate; Wendy Baughman; Gregory Strayhorn; Kevin Sullivan; Monica M Farley
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

10.  Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease.

Authors:  Jeffrey Hord; Rebecca Byrd; Laura Stowe; Beth Windsor; Kim Smith-Whitley
Journal:  J Pediatr Hematol Oncol       Date:  2002 Aug-Sep       Impact factor: 1.289
View more
  25 in total

Review 1.  The natural history of sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

Review 2.  Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.

Authors:  Satheesh Chonat; Charles T Quinn
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin.

Authors:  Jeffrey D Lebensburger; Thad Howard; Yunming Hu; Tamara I Pestina; Geli Gao; Melissa Johnson; Stanislav S Zakharenko; Russell E Ware; Elaine I Tuomanen; Derek A Persons; Jason W Rosch
Journal:  Blood       Date:  2011-11-30       Impact factor: 22.113

4.  Sickle cell disease: a comprehensive program of care from birth.

Authors:  Mariane de Montalembert; Léon Tshilolo; Slimane Allali
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

5.  Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

Authors:  Sara Christina Sadreameli; Megan E Reller; David G Bundy; James F Casella; John J Strouse
Journal:  Pediatr Blood Cancer       Date:  2014-01-31       Impact factor: 3.167

6.  Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure.

Authors:  Timothy L McCavit; Lei Xuan; Song Zhang; Glenn Flores; Charles T Quinn
Journal:  Pediatr Blood Cancer       Date:  2011-07-25       Impact factor: 3.167

Review 7.  Sickle cell disease in children.

Authors:  Emily Riehm Meier; Jeffery L Miller
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

Review 8.  Sickle cell disease in childhood: from newborn screening through transition to adult medical care.

Authors:  Charles T Quinn
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

9.  Impact of hydroxyurea on clinical events in the BABY HUG trial.

Authors:  Courtney D Thornburg; Beatrice A Files; Zhaoyu Luo; Scott T Miller; Ram Kalpatthi; Rathi Iyer; Phillip Seaman; Jeffrey Lebensburger; Ofelia Alvarez; Bruce Thompson; Russell E Ware; Winfred C Wang
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

10.  Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.

Authors:  Amanda B Payne; Ruth Link-Gelles; Ijeoma Azonobi; W Craig Hooper; Bernard W Beall; James H Jorgensen; Billie Juni; Matthew Moore
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.